| Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer |
Naloxegol, Placebo, Laboratory Biomarker Analysis, Quality-of-Life Assessment |
Active, not recruiting |
| Nashville Early Diagnosis Lung Cancer Project |
Computerized tomography (CT) scan of the chest, Pulmonary function tests, Nasal brushings, Urine sample, Bronchoscopy, Blood sample collection, Bronchoalveolar lavage, Questionnaire-data collection, Buccal epithelium collection, Sputum sample |
Active, not recruiting |
| National Cancer Institute "Cancer Moonshot Biobank" |
Biospecimen Collection, Medical Chart Review |
Recruiting |
| NCI COVID-19 in Cancer Patients, NCCAPS Study |
Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer |
Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure |
Active, not recruiting |
| Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer |
Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment |
Recruiting |
| Neuropsychological and Behavioral Testing in Younger Patients With Cancer |
Cognitive Assessment, Quality-of-Life Assessment |
Recruiting |
| New Assessment System in Measuring Symptom Distress in Cancer Patients |
Interview, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
| Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer |
Questionnaire Administration, Paclitaxel, Placebo, Nilotinib, Nilotinib Hydrochloride Monohydrate |
Recruiting |
| NR in Chemo-induced Peripheral Neuropathy |
Nicotinamide Riboside |
Recruiting |
| Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery |
Placebo Administration, Laboratory Biomarker Analysis, Nutritional Intervention, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients |
Olanzapine, Megestrol Acetate, Questionnaire Administration |
Recruiting |
| Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy |
Palonosetron Hydrochloride, Ondansetron Hydrochloride, Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Placebo |
Active, not recruiting |
| Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention |
omega 3 fatty acids |
Active, not recruiting |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer |
Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment |
Active, not recruiting |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery |
Questionnaire Administration, Placebo Administration, Endoxifen Hydrochloride |
Active, not recruiting |
| Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens |
Bazedoxifene and Conjugated Estrogens |
Recruiting |
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer |
Endocrine therapy interruption |
Active, not recruiting |
| Prevention of Oral DNA Damage by Black Raspberries |
BRB Lozenges |
Recruiting |
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients |
Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine |
Active, not recruiting |